ArticleEye (London, England)2025

Analysis of quantitative OCT and SS-OCTA metrics three months after initiation of intravitreal faricimab for treatment-recalcitrant neovascular AMD.

Arnold Nadel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.